BioinksBioprintingDistribution

Funakoshi to distribute Humabiologics bioinks in Japan

Non-exclusive deal centers on human-derived biomaterials

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Humabiologics entered into a non-exclusive agreement with Funakoshi to respond to the growing demand of human-derived biomaterials and bioinks serving a broader life sciences customer base of industry partners and academic institutions in the Japanese market.

Humabiologics develops and commercializes high-quality and affordable human-derived biomaterials for translational regenerative medicine applications such as cell therapy, bioprinting, tissue & disease modeling, or drug screening. Funakoshi Co., Ltd, is a leader in manufacturing and distributing life sciences research supplies for 50 years in Japan.

Funakoshi to distribute Humabiologics bioinks in Japan through non-exclusive deal that centers on human-derived biomaterials for bioprinting

“We are delighted to partner with Funakoshi to make our human products more accessible to researchers in Japan. Funakoshi is a strategic partner with long history and reputation of manufacturing and distributing of life sciences reagents and equipment for life sciences research”, said Dr. Mohammad Albanna, CEO & Founder of Humabiologics. “We look forward to a long-lasting relationship with Funakoshi and to serve their customers with our products to accelerate the development of life-saving human therapies”.

Funakoshi has been offering several useful tools with leading-edge technologies for Japanese researchers from all over the world to support and develop their research. Humabiologics introduced the world’s first native human collagen bioinks and gelatin bioinks. These bioinks are affordable and more clinically relevant, enabling researchers to advance the translational research of bioprinted human organs and tissues.

The company was founded by current CEO Mohammad Albanna, leveraging extensive experience in the field of Tissue Engineering and Regenerative Medicine (as Adjunct Professor of General Surgery at the Wake Forest University School of Medicine). Leveraging proprietary processes to manufacture its products, Humabiologics only partners with FDA-registered and accredited tissue banks around the US to utilize thoroughly screened donated human tissue that will not be used for transplant. Humabiologics product offering includes native human collagen, bone gelatin, and extracellular matrix. These human-derived products are designed to address several ongoing challenges.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based 3dpbm. Today the company publishes the leading news and insights websites 3D Printing Media Network and Replicatore, as well as 3D Printing Business Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!